News|Articles|April 2, 2003
- Pharmaceutical Technology-04-02-2003
- Volume 27
- Issue 4
Overhauling Compliance and GMPs
Author(s)Jill Wechsler
FDA's newly launched risk-based approach to GMP regulation spurs signficant changes in the agency's approach to inspection processes, postapproval changes, and 21 CFR Part 11 enforcement.
Advertisement
Articles in this issue
over 22 years ago
Outsourcing Outlookover 22 years ago
April 2003over 22 years ago
Identification of Out-of-Trend Stability ResultsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
PharmTech Weekly News Roundup – Week of December 1, 2025
3
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
4
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
5
